Literature DB >> 6359988

Nifedipine in the prevention of asthma induced by exercise and histamine.

P A Corris, S Nariman, G J Gibson.   

Abstract

Eight young men with documented exercise-induced asthma each performed two standard exercise tests and underwent two histamine challenges on separate days after double blind administration of either 20 mg nifedipine or placebo. The response to exercise was assessed by the maximal fall in forced expiratory volume in one second (FEV1) and to inhaled histamine by calculating the dose that produced a 20% fall in FEV1 (PC20). After premedication with nifedipine, the severity of exercise-induced asthma was significantly reduced (mean percent fall in FEV1, 6%, compared with 24% after placebo) and reactivity to histamine was reduced (geometric mean PC20, 1.68 mg X ml-1, compared with 0.46 mg X ml-1 after placebo). These results imply that nifedipine has a direct action on bronchial smooth muscle contractility but they do not exclude an additional effect on the secretion of chemical mediators from mast cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6359988     DOI: 10.1164/arrd.1983.128.6.991

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  13 in total

1.  Efficacy of calcium channel blockers as maintenance therapy for asthma.

Authors:  Mary Ann Twiss; Eloise Harman; Sarah Chesrown; Leslie Hendeles
Journal:  Br J Clin Pharmacol       Date:  2002-03       Impact factor: 4.335

2.  The effect of diltiazem, a calcium channel blocker, in asthmatic patients.

Authors:  Francesca Quintieri; Antonella D'Ambrosio; Alessandra Bachetoni
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

Review 3.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 4.  Calcium channel blockers and asthma.

Authors:  S Y So; M Ip; W K Lam
Journal:  Lung       Date:  1986       Impact factor: 2.584

Review 5.  Heterogeneity of calcium channels in mast cells and basophils and the possible relevance to pathophysiology of lung diseases: a review.

Authors:  N Chand; J L Perhach; W Diamantis; R D Sofia
Journal:  Agents Actions       Date:  1986-03

Review 6.  The management of hypertension.

Authors:  B N Prichard; C W Owens
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

Review 7.  Clinical studies with calcium antagonists in asthma.

Authors:  P J Barnes
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

8.  Effect of nifedipine on arterial hypoxaemia occurring after methacholine challenge in asthma.

Authors:  E Ballester; J Roca; R Rodriguez-Roisin; A Agusti-Vidal
Journal:  Thorax       Date:  1986-06       Impact factor: 9.139

9.  Inhibition of exercise-induced asthma by nifedipine: a dose-response study.

Authors:  P Rafferty; J G Varley; J S Edwards; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1987-10       Impact factor: 4.335

10.  The obligatory role of calcium in the development of antigen-induced airway hyperreactivity to cold provocation in the rat isolated trachea.

Authors:  N Chand; W Diamantis; R D Sofia
Journal:  Br J Pharmacol       Date:  1987-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.